Article

Computationally Repurposing Drugs for Breast Cancer Subtypes Using a Network-Based Approach

2021-09-08

Abstract excerpt

'De novo' drug discovery is costly, slow, and with high risk. Repurposing known drugs for treatment of other diseases offers a fast, low-cost/risk and highly-efficient method toward development of efficacious treatments. The emergence of large-scale heterogeneous biomolecular networks, molecular, chemical and bioactivity data, and genomic and phenotypic data of pharmacological compounds is enabling the development...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 4e5ffea7-3e08-5f22-9b1c-d9bf500da3e1
DOI: 10.21203/rs.3.rs-655605/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Computationally Repurposing Drugs for Breast Cancer Subtypes Using a Network-Based ApproachDOI 10.21203/rs.3.rs-655605/v1Read

Computationally repurposing drugs for breast cancer subtypes using a network-based approachSemantic proximity Read

Exploring Drug-Target Interactions through Network Pharmacology in Breast cancer: A Text Mining ApproachSemantic proximity Read

Disease networks and their contribution to disease understanding and drug repurposing: Evolution of the concept, techniques and data sourcesSemantic proximity Read

An Integrated Knowledge Graph and Network Medicine Pipeline for Drug Repurposing: Benchmarking Across Human Diseases and Application to Amyotrophic Lateral SclerosisSemantic proximity Read

Prioritization of Potential Drugs Through Pathway-Based Drug Repurposing and Network Proximity AnalysisSemantic proximity Read

An Integrative Drug Repurposing Pipeline: Switching Viral Drugs to Breast Cancer.Semantic proximity Read

NPDI-BcCov: A Network Pharmacology Approach for Simultaneous Inference of Drugs Targeting Breast Cancer and COVID-19Semantic proximity Read

The Drug Repurposing Encyclopedia (DRE): a web server for systematic drug repurposing across 20 organismsSemantic proximity Read

Drug Repurposing through Meta-path Reconstruction using Relationship EmbeddingSemantic proximity Read

Computational drug repositioning through heterogeneous network clustering.Semantic proximity Read

Network-based estimation of therapeutic efficacy and adverse reaction potential for prioritisation of anti-cancer drug combinationsSemantic proximity Read

A network model for patient-derived drug response in breast cancer integrating multi-omics datasetsSemantic proximity Read